More importantly, blocking the EGFR phospho-transferase activity severely affected SSc IgG-induced activation of these early signaling events, suggesting a role for the EGFR's catalytic activity in the cellular response to SSc IgG (Fig. 3C). Here, EGFR is linked to systemic sclerosis.